Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edwards Lifesciences Corp EW

Healthcare Medical Devices
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter... see more

Recent & Breaking News (NYSE:EW)

Providence Partners with Edwards Lifesciences, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to Open Two Free Mass COVID-19 Vaccination Clinics

PR Newswire April 21, 2021

Edwards Lifesciences Reports First Quarter Results

PR Newswire April 20, 2021

Edwards Lifesciences To Host Earnings Conference Call On April 20, 2021

PR Newswire April 13, 2021

Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years

PR Newswire January 31, 2021

Edwards Lifesciences Reports Fourth Quarter Results

PR Newswire January 27, 2021

Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021

PR Newswire January 13, 2021

Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease

PR Newswire December 21, 2020

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Canada

Canada NewsWire December 18, 2020

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference

PR Newswire December 10, 2020

Edwards Lifesciences Reports Third Quarter Results

PR Newswire October 21, 2020

Edwards Lifesciences To Host Earnings Conference Call On October 21, 2020

PR Newswire October 7, 2020

Edwards Lifesciences Reports Second Quarter Results

PR Newswire July 23, 2020

Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries

PR Newswire July 15, 2020

Paul LaViolette Appointed To Edwards Lifesciences Board Of Directors

PR Newswire July 15, 2020

Edwards Lifesciences Agrees To Global Transcatheter Litigation Settlement With Abbott

PR Newswire July 13, 2020

Edwards Lifesciences To Host Earnings Conference Call On July 23, 2020

PR Newswire July 9, 2020

Edwards SAPIEN 3 Transcatheter Heart Valve Receives Approval In China

PR Newswire June 8, 2020

Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair

PR Newswire May 18, 2020

Edwards Announces Updates From Annual Meeting

PR Newswire May 7, 2020

Edwards Lifesciences Announces May 2020 Investor Conference Schedule

PR Newswire May 5, 2020